AA
TLSI icon

AQR Arbitrage’s TriSalus Life Sciences TLSI Stock Holding History

AQR Arbitrage’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400,717
Closed -$3.98M – 1253
2022
Q3 		$3.98M Buy
400,717
+265,000
+195% +$2.62M 0.09% 318
2022
Q2 		$1.33M Buy
135,717
+50,000
+58% +$491K 0.03% 528
2022
Q1 		$840K Sell
85,717
-36,513
-30% -$360K 0.02% 518
2021
Q4 		$1.21M Hold
122,230
– – 0.03% 566
2021
Q3 		$1.21M Sell
122,230
-10,000
-8% -$97.9K 0.03% 408
2021
Q2 		$1.29M Buy
132,230
+67,730
+105% +$664K 0.04% 384
2021
Q1 		$622K Buy
+64,500
New +$654K 0.02% 512

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AQR Arbitrage's TLSI Position: Q4 2022 in Review

AQR Arbitrage sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 400,717 shares — an estimated $3.98M sold.

AQR Arbitrage first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $3.98M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • AQR Arbitrage reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • AQR Arbitrage sold 400,717 TriSalus Life Sciences shares in Q4 2022, an estimated $3.98M.
  • AQR Arbitrage first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • AQR Arbitrage's TriSalus Life Sciences position peaked at $3.98M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.